James B. Bucher

Insider Reports History

Location
Bothell, WA
Signature
/s/ James B. Bucher
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James B. Bucher:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. Chief Legal Officer Stock Option (Right to Buy) 100,000 08 Jan 2026 Direct
Eliem Therapeutics, Inc. EVP and General Counsel Stock Option (Right to Buy) 95,000 31 Oct 2022 Direct
Harpoon Therapeutics, Inc. Chief Legal Officer Employee Stock Option (Right to Buy) 0 11 Mar 2024 Direct

Insider Reports Filed by James B. Bucher

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZNTL Zentalis Pharmaceuticals, Inc. 08 Jan 2026 1 $0 4 Chief Legal Officer 09 Jan 2026, 20:35
ZNTL Zentalis Pharmaceuticals, Inc. 01 Oct 2025 1 $0 4 Chief Legal Officer 01 Oct 2025, 18:40
ZNTL Zentalis Pharmaceuticals, Inc. 18 Sep 2025 0 $0 3 Chief Legal Officer 22 Sep 2025, 16:10
/report/000095017024029425-bucher-james-b-2024-03-11 Harpoon Therapeutics, Inc. 11 Mar 2024 1 $0 4 Chief Legal Officer 11 Mar 2024, 17:15
/report/000095017023073031-bucher-james-b-2023-12-21 Harpoon Therapeutics, Inc. 21 Dec 2023 1 $0 4 Chief Legal Officer 26 Dec 2023, 16:10
/report/000095017023073023-bucher-james-b-2023-12-21 Harpoon Therapeutics, Inc. 21 Dec 2023 0 $0 3 Chief Legal Officer 26 Dec 2023, 16:05
CLYM Eliem Therapeutics, Inc. 31 Oct 2022 1 $0 4 EVP and General Counsel 02 Nov 2022, 19:06
CLYM Eliem Therapeutics, Inc. 27 Jan 2022 1 $0 4 EVP and General Counsel 31 Jan 2022, 16:06
CLYM Eliem Therapeutics, Inc. 09 Aug 2021 0 $0 3 EVP and General Counsel 09 Aug 2021, 18:13